TraceLink protects the medicine supply against drug shortages, external manufacturing issues, and supply chain disruption, providing critical visibility, process collaboration, and actionable intelligence for life science companies and their network partners. Let’s connect at the AAM Annual Meeting to talk about how TraceLink helped protect over 500,000 patients from drug shortages in 2023. Learn more: https://lnkd.in/etVSQNB #SupplyChainOrchestration #DrugShortages #Pharma #Pharmaceutical #Access!
TraceLink’s Post
More Relevant Posts
-
TraceLink protects the medicine supply against drug shortages, external manufacturing issues, and supply chain disruption, providing critical visibility, process collaboration, and actionable intelligence for life science companies and their network partners. Let’s connect at the AAM Annual Meeting to talk about how TraceLink helped protect over 500,000 patients from drug shortages in 2023. Learn more: https://lnkd.in/etVSQNB #SupplyChainOrchestration #DrugShortages #Pharma #Pharmaceutical #Access!
-
-
TraceLink protects the medicine supply against drug shortages, external manufacturing issues, and supply chain disruption, providing critical visibility, process collaboration, and actionable intelligence for life science companies and their network partners. Let’s connect at the AAM Annual Meeting to talk about how TraceLink helped protect over 500,000 patients from drug shortages in 2023. Learn more: https://lnkd.in/etVSQNB #SupplyChainOrchestration #DrugShortages #Pharma #Pharmaceutical #Access!
-
-
TraceLink protects the medicine supply against drug shortages, external manufacturing issues, and supply chain disruption, providing critical visibility, process collaboration, and actionable intelligence for life science companies and their network partners. Let’s connect at the AAM Annual Meeting to talk about how TraceLink helped protect over 500,000 patients from drug shortages in 2023. Learn more: https://lnkd.in/etVSQNB #SupplyChainOrchestration #DrugShortages #Pharma #Pharmaceutical #Access!
-
-
The Annual Report 2023 is now available! In addition to the essential financial section, we explore various facets of the past year. This includes an article highlighting our giant leap into clinical studies, along with an engaging interview featuring CTO Mats Silvander who was asked to encapsulate the Dicot culture in just three words. Read the Annual Report in Swedish here (English version will be released shortly): https://lnkd.in/dqsVPkxZ #annualreport2023 #pharma #pharmaceutical #drugdevelopment #sexualdysfunctions #erectiledysfunction #prematureejaculation #lifescience #kliniskastudier #läkemedelsutveckling #sexuelladysfunktioner #erektionssvikt #tidigutlösning
-
-
We just released the Q1-report. Elin´s opening words in her CEO-statement pretty much sums up how we feel right now: "Gratitude, joy, and strength. We experience a multitude of emotions after Dicot completed the first clinical study". Read the full interim report in English here: https://lnkd.in/dH9N7HYk And in Swedish here: https://lnkd.in/dcBcEGty #interimreport #clinicaltrials #pharma #pharmaceutical #drugdevelopment #sexualdysfunctions #erectiledysfunction #prematureejaculation #lifescience #kliniskastudier #läkemedelsutveckling #sexuelladysfunktioner #erektionssvikt #tidigutlösning
-
-
#Providers: What happens when a market access leader becomes the patient? Read an industry expert’s personal story and gain insights into enhancing access and support. Essential reading for healthcare professionals striving to achieve the Quintuple Aim. Learn more: https://lnkd.in/edN-4WKi Rocio Manghani David Dierk Kendig Bergstresser #patientjourney #tripleaim #quintupleaim #Aventria #pharmaceutical #marketaccess
-
NICE - National Institute for Health and Care Excellence would like to learn more about perceptions and understanding of its industry support service, NICE Advice, among #pharma and #healthtech innovators. Complete the survey below to have the opportunity to participate in a free NICE masterclass! 👇
📣 Calling all pharmaceutical or healthtech developers 📣 We would like to understand your awareness and perceptions of NICE’s industry support service, NICE Advice, in our short survey. Your feedback will be used to help shape future communications. Plus, completing the survey gives you the chance to participate in a publicly available NICE masterclass, free of charge. Complete survey: https://lnkd.in/gsgFDDP4 #pharmaceutical #healthtech
-
-
The article delves into the transformative role of Agile Clinical Research Organizations (CROs). CROs are pivotal in reshaping industry outcomes, transitioning to valued partners with strategies to boost productivity and satisfaction. Read the entire story https://lnkd.in/dzC9Z8cb #Agility #ClinicalResearch #Pharmaceutical #DestressToDeliver #ManagementConsulting #Innovation
-
-
When medications are forced to “compete” in a patient's body, no one wins—especially not the patient. Drug-drug-gene interactions create unhealthy competition, and traditional drug interaction systems don't consider that risk. We’ve designed the only platform that analyzes drug-drug, multi-drug, drug-gene, and drug-disease interactions to provide a truly comprehensive risk assessment, individualized down to the DNA. Learn more about the science behind GalenusRx's APPRAISE™ platform: https://lnkd.in/gS6u2VwJ #Healthcare #HealthTech #MedTech #Pharmaceutical #PharmaceuticalIndustry
-
When you are put in place to view through your audience's lens. A moving journey
#Providers: What happens when a market access leader becomes the patient? Read an industry expert’s personal story and gain insights into enhancing access and support. Essential reading for healthcare professionals striving to achieve the Quintuple Aim. Learn more: https://lnkd.in/edN-4WKi Rocio Manghani David Dierk Kendig Bergstresser #patientjourney #tripleaim #quintupleaim #Aventria #pharmaceutical #marketaccess
